Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 20, 2025
MCAN Health Celebrates 10 Years of Transforming Medical Travel in Turkey
EIN Presswire
·
March 20, 2025
ISTANBUL, TURKEY, March 20, 2025 /EINPresswire.com/ -- This year, MCAN Health celebrates its 10th anniversary, marking a decade of dedication to patient safety, personalized care, and innovation in the medical travel industry. Since its founding in 2015, …
Inaugural World Parasite Awareness Day Spotlights the Preventable Health Risk to Pets and People
EIN Presswire
·
March 20, 2025
BRUSSELS, BELGIUM, March 20, 2025 /EINPresswire.com/ -- The first-ever World Parasite Awareness Day will be observed on March 20 as part of a global initiative to raise awareness about the dangers parasites pose to pets and people. The effort is backed …
Louisiana Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a Person with Mesothelioma or Lung Cancer Anywhere in Louisiana Who Used Baby-Talcum Powder---Get the Best Possible Compensation Results
EIN Presswire
·
March 20, 2025
NEW ORLEANS , LA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- According to the Louisiana Mesothelioma Victims Center, "We have endorsed, and we recommend the Gori Law Firm for a person who has developed mesothelioma or lung cancer-especially if …
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
GlobeNewswire
·
March 20, 2025
Clinical hold lifted for late stage cadisegliatin program for diabetes CATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to resume Q2 2025 Strengthens commercial leadership with appointment of Martin Lafontaine as Chief Commercial Officer …
Creative Biolabs: Model Development Solutions Against Alzheimer's Disease
EIN Presswire
·
March 20, 2025
Creative Biolabs has expanded its product offerings to include advanced animal models and in vitro assays to advance research into Alzheimer's disease. SHIRLEY, NY, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Creative Biolabs, a highly respected …
FmPro Migrator 11.39 Adds Migration of COBOL to Java, C# & Python Using the Code Conversion Workbench
EIN Presswire
·
March 20, 2025
The automated transformation of COBOL to 50+ languages is performed by using the latest public …
Mesotherapy Market to Reach USD 1,293.2 Million by 2034, Growing at 10.2% CAGR | Fact.MR Report
EIN Presswire
·
March 20, 2025
Cost-Effective Nature of the Treatments is Seeing Mesotherapy’s Status Rise ROCKVILLE, MD, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- The global mesotherapy market is estimated to be US$ 489.4 million in 2024. The market is projected to rise at …
YourUpdate TV Speaks with Mia Syn About National Nutrition Month
GlobeNewswire
·
March 20, 2025
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- March is National Nutrition Month, a time to focus on making informed choices about food, supplements, and nutrition to develop healthy habits. Registered dietitian and nationally recognized nutrition expert, …
Custom Recombinant Protein Production Services Market Is Booming Worldwide 2025-2032: Proteos Inc., Kempbio, Inc, Abgent
EIN Presswire
·
March 20, 2025
custom recombinant protein production services market is estimated to be valued at US$ 4.9 billion in 2023 and is expected to exhibit a CAGR of 11.5% by 2030 BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
Sleep Aids Market Projected To Witness Substantial Growth, 2025-2032: Pfizer Inc., GSK plc, Cadwell Industries, Inc.
EIN Presswire
·
March 20, 2025
Sleep Aids Market is estimated to be valued at USD 83.75 Bn in 2025 and is expected to reach USD 141.77 Bn by 2032, exhibiting a CAGR of 7.8% from 2025 to 2032 BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
Wearable Sensors Market Projected To Witness Substantial Growth, 2025-2032: Google, Amazon, Apple, Microsoft, Facebook
EIN Presswire
·
March 20, 2025
Wearable sensors are the devices that collect information about biological…
Nursing Care Services Market Projected To Witness Substantial Growth 2025-2032:Linacre Inc, Genesis healthcare, Genitive
EIN Presswire
·
March 20, 2025
At the nursing care services center, trained professionals provide care facilities such as dressing, personal hygiene, and timely medications BURLINGAME, CA, UNITED STATES, March 20, 2025 /EINPresswire.com/ -- Latest Report, titled “Nursing Care …
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
GlobeNewswire
·
March 20, 2025
Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25 Progression of preclinical next-generation APJ agonists for obesity New platform partnerships with Novartis and Lilly to discover and develop novel …
BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
GlobeNewswire
·
March 20, 2025
MELVILLE, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
GlobeNewswire
·
March 20, 2025
GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, today announced that its Compensation Committee …
Context Therapeutics Reports Full Year 2024 Operating and Financial Results
GlobeNewswire
·
March 20, 2025
CTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, March 20, 2025 (GLOBE NEWSWIRE) -- Context …
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
GlobeNewswire
·
March 20, 2025
– Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline – – Interim Phase 1b proof-of-concept data, including initial efficacy measures, anticipated in fall 2025 for ABI-5366 and …
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 20, 2025
- Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced a clinical trial supply agreement with Regeneron …
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
GlobeNewswire
·
March 20, 2025
Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25 First patient enrolled in Phase 2 FALCON trial of TERN-601 for obesity with 12-week data …
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2024 Earnings and Conference Call Information
GlobeNewswire
·
March 20, 2025
WESTBROOK, Maine, March 20, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the fourth quarter …